Valuation: IXICO plc

Market Cap 17.99M 24.04M 21.01M 19.29M 34.1M 2.29B 34.68M 232M 90.01M 1.12B 90.27M 88.31M 3.87B P/E 2026 *
-5.16x
P/E 2027 * -6.35x
Enterprise Value 8.39M 11.21M 9.8M 9M 15.9M 1.07B 16.17M 108M 41.97M 523M 42.09M 41.18M 1.8B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 1.37x
Free-Float
89.25%
Yield 2026 *
-
Yield 2027 * -
1 week-2.37%
Current month-0.60%
1 month-4.62%
3 months+4.76%
6 months-29.79%
Current year-29.79%
1 week 8
Extreme 8
8.6
1 month 8
Extreme 8
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap.
25-06-12Free 350,000 0.3777%
25-06-12Buy

Chief Financial Officer

45,263 0.0488%
25-06-12Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.37%-18.72%-56.58% 24.04M
+0.36%+5.10%+1.04%+5.85% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+2.38%+8.10%+21.83%+66.94% 33.09B
+1.20%+2.02%+9.79%+32.43% 25.19B
+2.51%+4.94% - - 17.05B
+2.58%+7.24%+71.03%+132.17% 15.92B
+0.99%+1.26%+13.98%+18.88% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
Average +1.17%+5.55%+60.92%+85.38% 24.23B
Weighted average by Cap. +1.29%+6.73%+88.25%+130.71%

Financials

2026 *2027 *
Net sales 7.5M 10.02M 8.76M 8.04M 14.22M 954M 14.46M 96.83M 37.53M 468M 37.63M 36.82M 1.61B 9M 12.03M 10.51M 9.65M 17.06M 1.15B 17.35M 116M 45.03M 562M 45.16M 44.18M 1.94B
Net income -2.4M -3.21M -2.8M -2.57M -4.55M -305M -4.63M -30.99M -12.01M -150M -12.04M -11.78M -516M -2.8M -3.74M -3.27M -3M -5.31M -356M -5.4M -36.15M -14.01M -175M -14.05M -13.74M -602M
Net Debt -9.6M -12.83M -11.21M -10.29M -18.2M -1.22B -18.51M -124M -48.03M -599M -48.17M -47.13M -2.06B -5.7M -7.62M -6.66M -6.11M -10.81M -725M -10.99M -73.59M -28.52M -356M -28.6M -27.98M -1.23B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-07-02 GBX 8.250 0.00% 81,657
26-07-01 GBX 8.250 -0.60% 7,600
26-06-30 GBX 8.300 -1.78% 86,425
26-06-29 GBX 8.450 0.00% 4,484
26-06-26 GBX 8.450 0.00% 155
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0825GBP
Average target price
0.2600GBP
Spread / Average Target
+215.15%

Annual profits - Rate of surprise